<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: catalyst</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'catalyst'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22catalyst%22&t=%22catalyst%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 03:00:40 +0100</lastBuildDate>
        <item>
            <title>Consumer Groups Ask FTC To Split CVS Caremark</title>
            <link>http://www.medworm.com/index.php?rid=4715014&amp;cid=t_174882_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FpYq3k6eZCQ4%2F</link>
            <description>Four years after the merger between the CVS drugstore chain and the Caremark pharmacy benefits manager, which has spurred numerous investigations and lawsuits over anticompetitive concerns, a handful of consumer groups have written the US Federal Trade Commission to ask the agency to break up the company. 
Why? The groups charge CVS Caremark limits choice through various programs, the merger has given CVS unfair advantage over other retailers, patients are steered toward CVS and confidential patient information is improperly shared. Such concerns have already prompted investigations by the FTC and attorneys general of 24 states. CVS Caremark has previously said it is cooperating with the probes.
“There is strong evidence that the CVS Caremark merger has harmed consumers,” says the lett...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4715014</comments>
            <pubDate>Fri, 15 Apr 2011 12:18:08 +0100</pubDate>
            <guid isPermaLink="false">4715014</guid>        </item>
        <item>
            <title>Best of Our Blogs: April 1, 2011</title>
            <link>http://www.medworm.com/index.php?rid=4664228&amp;cid=t_174882_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F04%2F01%2Fbest-of-our-blogs-april-1-2011%2F</link>
            <description>Happy April Fool&amp;#8217;s Day!
Will you be partaking in this prank-filled holiday? Let&amp;#8217;s say not only are you not participating, but you are hiding from those who are. Maybe you should reconsider and embrace the practical joking for today. Think I&amp;#8217;m crazy?
In a 2008 New York Times article called, &amp;#8220;April Fool! The Purpose of Pranks,&amp;#8221; reporter Benedict Carey wrote about the psychology behind pranks. Interestingly, he found that initiation rites and coming of age rituals were a way to introduce a person to a group. The anger and embarrassment from being pranked may evoke a sense of self-awareness and self-reflection. Why? Being vulnerable and getting fooled opens up a whole can of worms getting us to question what we did or didn&amp;#8217;t do that caused us to fall for a ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4664228</comments>
            <pubDate>Fri, 01 Apr 2011 10:57:59 +0100</pubDate>
            <guid isPermaLink="false">4664228</guid>        </item>
        <item>
            <title>History of a Suicide: An Interview with Jill Bialosky</title>
            <link>http://www.medworm.com/index.php?rid=4664229&amp;cid=t_174882_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F03%2F31%2Fhistory-of-a-suicide-an-interview-with-jill-bialosky%2F</link>
            <description>Today I have the pleasure of interviewing Jill Bialosky, author of the new book History of a Suicide: My Sister&amp;#8217;s Unfinished Life, in which she brilliantly weaves together her sister&amp;#8217;s inner life and brings an awkward but essential topic of discussion out of the shadows.
1. If you could have readers leave with one piece of truth about suicide, what would it be?
Jill: Suicide is a multi-faceted, complex event and though there may be a present catalyst that triggers it, ultimately it is a psychological drama that happens within the mind of a suicidal individual resulting from intense inner pain. This is a theory developed by Dr. Edwin Shneidman, one of the leading figures in the study of suidiology and it is the one theory that makes sense to me.
We must recognize the inner pain ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4664229</comments>
            <pubDate>Thu, 31 Mar 2011 15:24:08 +0100</pubDate>
            <guid isPermaLink="false">4664229</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=4183542&amp;cid=t_174882_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FFN6F-fxK06c%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that NanoBio hired Ali Fattom as senior vice president of vaccine research and development, who will lead nanoemulsion-based intranasal and intramuscular vaccine programs. Most recently, he was vice president of research at Nabi Biopharmaceuticals a...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4183542</comments>
            <pubDate>Fri, 19 Nov 2010 12:56:37 +0100</pubDate>
            <guid isPermaLink="false">4183542</guid>        </item>
        <item>
            <title>Meeting My Mentors</title>
            <link>http://www.medworm.com/index.php?rid=3494571&amp;cid=t_174882_180_f&amp;fid=38607&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fsuccessbeginstoday%2FBHWQ%2F%7E3%2F06csG0JxH5U%2F</link>
            <description>I had an amazing experience yesterday. I attended the Catalyst West Leadership Conference in Irvine California where I was able to meet two of my social media mentors along with a cadre of other bloggers, tweeters and Facebook fans.

Chris Brogan had said something in a post a while back that came to life yesterday… If you want to get anywhere in Social Media you have to go to the conferences… you have to meet the people face-to-face and shake hands.
This really came to life for me… putting the faces to the avatars and putting the voices to their written words.
When I sat down at a table in the opening session, three gals sat down across from me and started talking among themselves. I could tell from the accents that they were from the south and one of them looked real familiar. It w...</description>
            <author>Success Begins Today</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3494571</comments>
            <pubDate>Thu, 22 Apr 2010 14:13:52 +0100</pubDate>
            <guid isPermaLink="false">3494571</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=3335570&amp;cid=t_174882_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJjQGsGxC9zw%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Archimedes Pharma hired Jeff Buchalter as ceo and president. Most recently, he was ceo at Enzon Pharmaceuticals, which is in the process of revamping its strategy under pressure from Carl Icahn and Dellacamera Capital. 
...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3335570</comments>
            <pubDate>Fri, 05 Mar 2010 12:40:16 +0100</pubDate>
            <guid isPermaLink="false">3335570</guid>        </item>
        <item>
            <title>Cats, The Matrix, and Acid Drops</title>
            <link>http://www.medworm.com/index.php?rid=2523074&amp;cid=t_174882_107_f&amp;fid=36672&amp;url=http%3A%2F%2Fwww.sciencebase.com%2Fscience-blog%2Fcats-the-matrix-and-acid-drops.html</link>
            <description>The Alchemist learns of a scalable cat this week as well as how the matrix is all important when it comes to identifying metabolites in a single drop of blood.
A small follow-up trial for prostate drug abiraterone demonstrates quality of life improvements in patients with the aggressive form of the disease, the same drug might also be used in treating breast cancer.
German researchers &amp;#8220;working at close to absolute zero&amp;#8221; have formulated the smallest drop of hydrochloric acid, showing that four water molecules and one HCl are all that is needed.
In physical science the giant intrinsic electroresistance has been demonstrated in a conventional ferroelectric film for the first time and could herald the development of a new high-density type of computer memory. It&amp;#8217;s the electri...</description>
            <author>Sciencebase Science Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2523074</comments>
            <pubDate>Fri, 26 Jun 2009 14:00:55 +0100</pubDate>
            <guid isPermaLink="false">2523074</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=1319575&amp;cid=t_174882_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F255470864%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs being announced each month. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
Sygnis Pharma hired Frank Rathgeb as chief medical officer;
Catalyst named Pat Kenny director of corporate clinical compliance;
Maxygen promoted Grant Yonehiro to chief business officer;
Zimmer Holdings added Bob Hagemann, a Quest sr vp and cfo to its board;
Zimmer Holdings also added Cecil Pickett, Biogen Idec&amp;#8217;s R&amp;#038;D chief, to its board...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1319575</comments>
            <pubDate>Fri, 21 Mar 2008 11:35:24 +0100</pubDate>
            <guid isPermaLink="false">1319575</guid>        </item>
        <item>
            <title>Cocaine Treatment Gives Investors A High</title>
            <link>http://www.medworm.com/index.php?rid=1079861&amp;cid=t_174882_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F196849783%2F</link>
            <description>Nostrils were wide open on Wall Street today to take in the results of a study for vigabatrin, an experimental med that is being tested to fight cocaine addiction. Shares in Catalyst Pharmaceuticals rose more than 11 percent following publicity about a Phase II study showing the drug worked in a meaningful number of patients, who were prison parolees. 
The results indicated a statistically significantly greater number of patients given vigabatrin were able to abstain from cocaine during the last three weeks of the dosing period, compared to those receiving placebo. The primary outcome measure of the trial was negative urine tests for cocaine for the last three weeks of the nine-week trial, and a total of 18 patients, or 42 percent of the 103 who were enrolled, fulfilled the criteria. Of th...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1079861</comments>
            <pubDate>Fri, 07 Dec 2007 22:15:58 +0100</pubDate>
            <guid isPermaLink="false">1079861</guid>        </item>
    </channel>
</rss>

